After getting FDA approval to market its first artificial-intelligence cardiac tool, Singapore-based health technology company Biofourmis Inc. is moving its headquarters to Boston.

Biofourmis is developing several pieces of technology that use artificial intelligence to detect and track signs of multiple sclerosis, asthma and other conditions. It received its first FDA clearance last month for a heartbeat-tracking software called RhythmAnalytics, which the company said more accurately detects…

Boston Biz Journal https://www.bizjournals.com/boston/news/2019/05/21/medtech-firm-biofourmis-to-move-hq-to-boston.html?ana=RSS&s=article_search